Cargando…

Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-2019 is a new global health challenge which causes severe respiratory complications. As of May 17th, 2020, SARS-CoV-2 has infected 4.6 million people and caused 310,000 deaths, worldwide. In order to study potential impact of infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Hassan, Wahid, Braira, Rubi, Ghazala, Gulzar, Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242943/
https://www.ncbi.nlm.nih.gov/pubmed/32450246
http://dx.doi.org/10.1016/j.meegid.2020.104374
_version_ 1783537332640546816
author Raza, Hassan
Wahid, Braira
Rubi, Ghazala
Gulzar, Adil
author_facet Raza, Hassan
Wahid, Braira
Rubi, Ghazala
Gulzar, Adil
author_sort Raza, Hassan
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-2019 is a new global health challenge which causes severe respiratory complications. As of May 17th, 2020, SARS-CoV-2 has infected 4.6 million people and caused 310,000 deaths, worldwide. In order to study potential impact of infection, complete epidemiological information should be reported on regular basis however, data from Pakistan has not yet been published. This retrospective study is the first report of epidemiological trends of COVID-19 in Faisalabad, Pakistan. On April 4th, 2020, 128 nasopharyngeal swabs collected from city Faisalabad were transported to Postgraduate Research Institute, Lahore for further processing. RNA was extracted using QIAsymphony DSP Virus/Pathogen Midi Kit and real-time PCR was performed to quantify COVID-19. Our finding showed that overall prevalence of COVID-19 in Faisalabad on April 4th was 17.18% (22 of 128). Prevalence was higher in males (n = 17; 77.2%) as compared to females (n = 5; 22.8%) but this gender-wise difference was not statistically significant. Patients belonging to age group 37–47 years were found to be most (45.5%) infected with COVID-19.
format Online
Article
Text
id pubmed-7242943
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-72429432020-05-22 Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience Raza, Hassan Wahid, Braira Rubi, Ghazala Gulzar, Adil Infect Genet Evol Article Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-2019 is a new global health challenge which causes severe respiratory complications. As of May 17th, 2020, SARS-CoV-2 has infected 4.6 million people and caused 310,000 deaths, worldwide. In order to study potential impact of infection, complete epidemiological information should be reported on regular basis however, data from Pakistan has not yet been published. This retrospective study is the first report of epidemiological trends of COVID-19 in Faisalabad, Pakistan. On April 4th, 2020, 128 nasopharyngeal swabs collected from city Faisalabad were transported to Postgraduate Research Institute, Lahore for further processing. RNA was extracted using QIAsymphony DSP Virus/Pathogen Midi Kit and real-time PCR was performed to quantify COVID-19. Our finding showed that overall prevalence of COVID-19 in Faisalabad on April 4th was 17.18% (22 of 128). Prevalence was higher in males (n = 17; 77.2%) as compared to females (n = 5; 22.8%) but this gender-wise difference was not statistically significant. Patients belonging to age group 37–47 years were found to be most (45.5%) infected with COVID-19. Published by Elsevier B.V. 2020-10 2020-05-22 /pmc/articles/PMC7242943/ /pubmed/32450246 http://dx.doi.org/10.1016/j.meegid.2020.104374 Text en © 2020 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Raza, Hassan
Wahid, Braira
Rubi, Ghazala
Gulzar, Adil
Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience
title Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience
title_full Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience
title_fullStr Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience
title_full_unstemmed Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience
title_short Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience
title_sort molecular epidemiology of sars-cov-2 in faisalabad, pakistan: a real-world clinical experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242943/
https://www.ncbi.nlm.nih.gov/pubmed/32450246
http://dx.doi.org/10.1016/j.meegid.2020.104374
work_keys_str_mv AT razahassan molecularepidemiologyofsarscov2infaisalabadpakistanarealworldclinicalexperience
AT wahidbraira molecularepidemiologyofsarscov2infaisalabadpakistanarealworldclinicalexperience
AT rubighazala molecularepidemiologyofsarscov2infaisalabadpakistanarealworldclinicalexperience
AT gulzaradil molecularepidemiologyofsarscov2infaisalabadpakistanarealworldclinicalexperience